牛磺熊去氧胆酸联合多烯磷脂酰胆碱治疗非酒精性脂肪性肝病患者疗效观察

doi:10.3969/j.issn.1672-5069.2015.05.026

Abstract

Wang Jun，Hu Cuilan，Wang Zhe，et al.. Clinical observation of tauroursodeoxycholic acid combined with polyene phosphatidylcholine in the treatment of patients with nonalcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 544-545.

References

[1] 何小荣，洪涛，余杰，等. 多烯磷脂酰胆碱联合二甲双胍治疗非酒精性脂肪肝的疗效观察. 实用临床医学，2010，11（10）:14-16.
[2] 吴颖.多烯磷脂酰胆碱治疗非酒精性脂肪肝38例疗效观察. 海南医学，2010，21（3）:52-53.
[3] 中华医学会肝脏病学分会.非酒精性脂肪性肝病诊治指南.中华肝脏病杂志，2006，14（3）:161-163.
[4] 黄德周.多烯磷脂酰胆碱治疗非酒精性脂肪肝80例.中国药业，2012，21（7）:49-50.
[5] 施军平，范建高. 2009年非酒精性脂肪肝病临床研究进展回顾. 实用肝脏病杂志，2010，13（1）:1-3.
[6] 李玉霞，黄丽娟. 多烯磷脂酰胆碱联合复方丹参治疗非酒精性脂肪肝42例. 宁夏医学杂志，2010，32（3）:279-281.
[7] 郭丽丽，刘近春. 多烯磷脂酰胆碱联合复方丹参治疗非酒精性脂肪肝疗效观察. 长治医学院学报，2009，23（2）:117-118.
[8] 黄可青，郑晓辉，庄见齐. 多烯磷脂酰胆碱治疗非酒精性脂肪肝疗效观察. 慢性病学杂志，2010，12（7）:619-620.
[9] 纪奕锋，洪万东，朱启槐. 左卡尼汀联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的效果. 实用医学杂志，2008，24（24）:4286-4287.
[10] 赵莉，潘晓莉，黄景荣. 牛磺熊去氧胆酸与熊去氧胆酸治疗肝硬化的临床效果比较. 世界华人消化杂志，2014，22（28）:4338-4344.
[11] 袁芳.牛磺熊去氧胆酸治疗单发胆囊结石疗效观察.现代预防医学，2012，39（16）:4310-4311.
[12] 周健，刘黎，黄丽雯，等. 牛磺熊去氧胆酸治疗非酒精性脂肪肝疗效观察. 实用肝脏病杂志，2014，17（1）:80-81.
[13] 张晓峰，王立福，白云峰，等. 泽泻联合熊去氧胆酸胶囊治疗非酒精性单纯性脂肪肝疗效观察. 中华中医药学刊，2012，30（2）:274.
[14] 曹荣，胡旭东，柏涛，等. 熊去氧胆酸与牛磺熊去氧胆酸联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的疗效比较. 中国药房，2013，24（4）:365-367.
[15] 汤守兵，孟忠吉，康健，等. 牛磺熊去氧胆酸治疗原发性胆汁性肝硬化临床研究. 湖北中医药大学学报，2014，16（2）:81-82.

Clinical observation of tauroursodeoxycholic acid combined with polyene phosphatidylcholine in the treatment of patients with nonalcoholic fatty liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.